Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-001329

Director sold 40,000 shares at an average $15.11 ($604,556)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Director 2023-01-03 Sale −23,382 $15.19 $355,067 1,222,381 D: show line 1 in the form
Walker Neal Director 2023-01-03 Sale −1,618 $16.16 $26,146 1,220,763 D: show line 2 in the form
Walker Neal Director 2023-01-04 Sale −15,000 $14.89 $223,343 1,205,763 D: show line 3 in the form
Open-market sales · 40,000 sh · avg $15.11 · $604,556
Loading xslF345X03/doc4.xml…